Nomogram for Predicting Risk of Cancer Therapy–Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Nomogram for Predicting Risk of Cancer Therapy–Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Background Cancer therapy–related cardiac dysfunction (CTRCD) is an important treatment‐limiting toxicity for patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer that adversely affects cancer and cardiovascular outcomes. Easy‐to‐use tools that incorporate readily acc...

Full description

Bibliographic Details
Main Authors: Anthony F. Yu, I‐Hsin Lin, Justine Jorgensen, Robert Copeland‐Halperin, Stephanie Feldman, Ishmam Ibtida, Amare Assefa, Michelle N. Johnson, Chau T. Dang, Jennifer E. Liu, Richard M. Steingart
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
breast cancer
cardio‐oncology
cardiotoxicity
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.029465

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.029465

Similar Items